On July 29, 2024, Resolian reported a data breach to the Attorney General of Massachusetts, revealing that certain company email accounts had been compromised. The breach resulted in unauthorized access to sensitive consumer information, including names, Social Security numbers, usernames, and passwords. Resolian has been working to address the breach and protect affected individuals.
Following the discovery of the breach, Resolian launched an investigation to determine the extent of the incident and the specific data that was accessed. The investigation confirmed that the unauthorized party gained access to employee email accounts containing confidential consumer information. This process helped identify the types of data exposed and the individuals affected.
Resolian has since completed its review of the compromised files and has begun sending out data breach notification letters to impacted individuals. These letters detail the specific types of information that were exposed and provide guidance on how to protect oneself from potential misuse. The company is committed to ensuring that affected individuals are informed and supported.
Resolian, formerly known as Alliance Pharma, is a biotechnology company based in Malvern, Pennsylvania. After acquiring Drug Development Solutions in May 2022, the company rebranded and now operates under the name Resolian. With over 291 employees and generating approximately $61 million in annual revenue, Resolian is involved in cell and gene therapy as well as analytical sciences for quality control and testing.
Reference:
